Wall Street Zen lowered its rating to 'hold' and BTIG raised its price objective to $110.00 for Edwards Lifesciences on August 26, 2026.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Wall Street Zen lowered its rating to 'hold' and BTIG raised its price objective to $110.00 for Edwards Lifesciences on August 26, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Edwards Lifesciences
American medical technology company